2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
6
Obesity
5
Sexual Infantilism
4
Craniopharyngioma
3
Pancreatic Neoplasms
2
Overweight
2
Weight Loss
1
Insulin Resistance
1
Fatty Liver
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus, Type 1
1
Interventions
Glucose Tolerance Test
2
penclomedine
1
atezolizumab
1
Triptorelin Pamoate
1
Tomography, X-Ray Computed
1
Proton Magnetic Resonance Spectroscopy
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Olive Oil
1
Metformin
1
Liquid Biopsy
1
Exenatide
1
Excitatory Amino Acids
1
Endosonography
1
Diet, Ketogenic
1
Blood Specimen Collection
1
Bevacizumab
1
Amino Acids, Essential
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatty Liver
×
Exenatide
×
Clear all
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts